Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer [Phase 3]
Phase 3 trial evaluating palbociclib for HR-positive, HER2-negative isolated locoregional recurrence of breast cancer. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy
A retrospective evaluation of ultrasound-assisted tumor surgery in breast-conserving therapy for breast cancer has completed (NCT07519668).
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
This study evaluated real-world effectiveness of palbociclib plus endocrine therapy as first- or second-line treatment for HR+/HER2- advance…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers [Phase 1]
Phase Ib trial evaluating adagrasib (KRAS G12C inhibitor) in combination with olaparib in KRAS G12C-mutated advanced solid tumors, focusing …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases [Phase 2]
Phase 2 trial evaluating cisplatin with or without veliparib in patients with recurrent or metastatic triple-negative or BRCA mutation-assoc…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer [Phase 2]
Phase 2 study evaluating TQB3616 capsules in combination with fulvestrant for advanced HR-positive, HER2-negative breast cancer has complete…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail [Phase 3]
A Phase 3 trial evaluating TQB3616 capsules in combination with fulvestrant versus placebo with fulvestrant in previously treated HR-positiv…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer [Phase 2]
Phase 2 study assessing the efficacy and safety of combining alpelisib with fulvestrant in Japanese men and postmenopausal women with advanc…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy [Phase 2]
Phase 2 study evaluating Coenzyme Q10 for neuroprotection against paclitaxel-induced neuropathy in breast cancer patients has completed. Spo…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain [Phase 3]
Phase IIIB/Phase 3 study evaluating capivasertib in combination with fulvestrant for advanced breast cancer in patients who relapsed or prog…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment [Phase 4]
Phase 4 clinical trial update evaluating the safety of alpelisib plus fulvestrant in men and postmenopausal women with HR-positive, HER2-neg…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection [NA]
This completed clinical trial evaluated the safety and performance of intraoperative light-signal detection during electrosurgical breast ca…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients [NA]
This entry reports a completed pilot study evaluating acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer [Phase 4]
A completed Phase 4 randomized trial compares personalized follow-up strategies with guideline-based follow-up in patients with early-stage …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer [Phase 3]
A Phase 3 study evaluating romiplostim for chemotherapy-induced thrombocytopenia in adults with non-small cell lung cancer, ovarian cancer, …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Risk Communication Within Mexican-American Families
This update summarizes a completed NHGRI-funded clinical trial that examined risk communication within Mexican-American families, with relev…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors [NA]
This completed clinical trial evaluated strategies to maximize energy and reduce fatigue in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating pembrolizumab with carboplatin and paclitaxel for Stage I triple-negative breast cancer is currently ac…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer [Phase 2]
A completed Phase 2 study evaluating hetrombopag olamine tablets for thrombocytopenia induced by anti-tumor therapy in patients with advance…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer [Phase 1]
A completed Phase 1 trial evaluated the combination of capecitabine and cemiplimab in patients with metastatic breast cancer, including horm…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Losartan in Prevention of Radiation-Induced Heart Failure [EARLY_Phase 1]
Early-phase trial evaluating losartan to prevent radiation-induced heart failure in patients with breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery [NA]
A completed clinical trial assessing a perioperative individually tailored psychological intervention for breast cancer surgery. The study s…